October 1, 2012

What is real world evidence (RWE), and why has it become a hot topic for pharmaceutical companies? One of NAI’s Senior Consultants, Jill E. Sackman, D.V.M., Ph.D., explained why RWE is suddenly on everyone’s mind, and what manufacturers can do to ensure they are meeting the growing demand for it to eyeforpharma’s Craig Sharp. In her interview, she describes how this is a departure for drug makers:

“As the economic challenges have increased, and the demand from payers for more robust or comparative evidence has increased, so has the need for RWE,” she says. “So in an increasingly economically-strained world, this has become important and that’s why we’ve seen it raise its head in the last couple of years, it’s highly relevant.”

For additional insight into this emerging area, click here to read the complete interview, Real World Series: Q&A with Jill Sackman, October 24, 2012.